Bayer (BAYRY) Q1 Earnings Beat, Crop Science Sales Decline

Published on 11 May 2023 on Zacks via Yahoo Finance

Bayer (BAYRY) Q1 Earnings Beat, Crop Science Sales Decline

Bayer AG BAYRY released first-quarter 2023 core earnings of 79 cents per American Depositary Receipt (“ADR”), which beat both the Zacks Consensus Estimate and our model estimate of 55 cents. The company reported earnings of 99 cents per ADR in the year-ago quarter.

However, total sales in the first quarter were $15.4 billion, missing the Zacks Consensus Estimate of $15.7 billion but beating our model estimate of $15 billion. Revenues were down from $16.4 billion reported in the year-ago quarter.

Shares of Bayer have gained 24.8% in the year so far compared with the industry’s growth of 3.2%.

Read the rest of the article

NYSE.NVS price evolution

SIX.NOVN price evolution

XETRA.BAYN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

News

Bayer (BAYRY) Q1 Earnings Beat, Crop Science Sales Decline

NYSE.NVS price evolution

SIX.NOVN price evolution

XETRA.BAYN price evolution

Want to become a better investor?

Here’s Why Bayer Aktiengesellschaft (BAYRY) Detracted in Q1

Individual investors account for 60% of Bayer Aktiengesellschaft's (ETR:BAYN) ownership, while...

Bayer Aktiengesellschaft (ETR:BAYN) Shares Could Be 42% Below Their Intrinsic Value Estimate

Bayer Aktiengesellschaft (ETR:BAYN) Delivered A Weaker ROE Than Its Industry

Here’s Why Bayer Aktiengesellschaft (BAYRY) Declined in Q2

Bayer (BAYRY) Cuts 2023 Outlook, Reports Preliminary Q2 Results

Is Bayer Aktiengesellschaft (ETR:BAYN) Trading At A 46% Discount?

Bayer's (BAYRY) Arrhythmia Prevention Drug Gets Fast Track Tag

Can Bayer Aktiengesellschaft (ETR:BAYN) Improve Its Returns?

Bayer (BAYRY) Q1 Earnings Beat, Crop Science Sales Decline